PMPatrick Morgan

Patrick Morgan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Patrick Morgan has a total of 12 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Minimally invasive cardiac output monitoring

    by Patrick Morgan, Nawaf Al-Subaie, Andrew Rhodes

    The measurement of cardiac output in the critically ill constitutes a vital part in the management of these patients. Minimally invasive techniques are gaining popularity as they allow continuous cardiac output monitoring while avoiding the risks associated with pulmonary artery catheterization. This article focuses on some of the commonly used minimally invasive devices that rely on pulse contour waveform analysis. The current studies in the literature that assess the validity and the clinical applications of calibrated and noncalibrated arterial waveform derived cardiac output devices are discussed. The minimally invasive cardiac output monitoring devices available differ in their methodology and application. Currently there is conflicting evidence as to the accuracy of some of these systems and further investigation into their clinical application is required.


  • Open Access

    Lack of renoprotective effect of i.v. N -acetylcysteine in patients with chronic renal failure

    by P. G. Morgan, M. Georghiou, F. Flynn, S. Jaggar, A. Ristikankare, T. Kuitunen, L. Uotila, A. Vento, R. Suojaranta-Ylinen, M. Salmenperä, et al.

    Editor—We read with interest the paper by Ristikankare and colleagues1 regarding the lack of renoprotective effect of N-acetylcysteine (NAC) in patients with pre-existing renal failure undergoing cardiac surgery. We feel that several aspects of this study require further comment. First, a recent meta-analysis of the use of NAC to prevent contrast-induced nephropathy in patients with renal impairment was inconclusive,2 therefore, reducing the evidence base for the rational use of NAC. We would also wish to question the inclusion of patients with plasma creatinine greater than 100 µmol litre−1, which is below the upper limit of normal for many laboratory results in the UK. Therefore, it seems likely that this study may have included patients with normal renal function. We suggest it would have been more appropriate to identify patients with established renal impairment using a more specific measure than plasma creatinine, such as Glomerular Filtration Rate or estimated creatinine clearance.3